HOKUTO and WJOG Unite to Advance Cancer Care Information Dissemination
On May 20, 2025, HOKUTO Inc., based in Shibuya, Tokyo, established a comprehensive business alliance with the West Japan Oncology Group (WJOG) to share vital medical information in the field of oncology. This partnership aims to create a robust platform for disseminating the latest research findings, clinical trial information, interviews with key figures in the oncology field, explanatory articles on various cancer types, and announcements for WJOG-hosted seminars.
HOKUTO, under the leadership of President Dr. Sota Yamashita and Chairman Hokuto Igarashi, has been heavily focused on disseminating medical information, particularly in oncology, which arises from a growing demand for reliable and relevant information among its 100,000 physician members. Likewise, WJOG, led by Chairman Nobuyuki Yamamoto, has dedicated over 30 years to improving cancer treatment in Japan through collaborative clinical trials and physician-led research. They have also fostered an environment where young researchers can propose and conduct clinical studies independently, which is crucial for developing the next generation of professionals in the field amidst an aging organization.
Key Initiatives from the Partnership
The collaboration is set to roll out several major initiatives:
1. Dissemination of the latest research results and clinical trial information.
2. Publication of interviews with WJOG and associated medical institutions.
3. Production of content that elaborates on various aspects of oncology.
4. Promotion of upcoming seminars organized by WJOG.
Comments from WJOG Leadership
Nobuyuki Yamamoto expressed his excitement about the partnership, emphasizing the critical need for a reliable platform that ensures the swift and accurate transfer of accumulated knowledge from clinical trials directly to practitioners’ hands. He noted that HOKUTO's clinical support app, used by over 100,000 physicians nationwide, will serve as an excellent foundation for this information-sharing endeavor.
Mitsugu Miura, chair of WJOG’s Educational and Public Relations Committee, echoed this sentiment, highlighting the practical tools available through HOKUTO that enhance clinical practice. He anticipates that this partnership will significantly increase the dissemination of relevant information about clinical trials and seminars, ultimately contributing to the advancement of cancer care and increasing awareness of WJOG's activities among HOKUTO users.
About WJOG
Founded as a voluntary organization on lung cancer treatment over three decades ago, WJOG transitioned to a certified NPO in 2015 and now oversees collaborative clinical trials across 386 institutions with approximately 920 members. Their consistent focus on bridging clinical research and practice has led to the creation of specialized groups for young physicians in various fields.
HOKUTO's Role
The HOKUTO clinical support app offers a comprehensive service that assists physicians in accessing essential medical information both during and after working hours. The app is designed to reduce the burden of sifting through vast amounts of medical literature, enabling physicians to directly improve patient outcomes effectively.
Company Overview
HOKUTO, an innovative healthcare IT startup, strives to alleviate the work burden of medical professionals by providing necessary tools for medical and clinical support. Their product suite includes the HOKUTO clinical support app, alongside student residency assistance and marketing solutions for healthcare companies. The mission statement emphasizes their commitment to seeking better outcomes for healthcare professionals worldwide.
For more information on HOKUTO, please visit HOKUTO's corporate site. For inquiries, you can reach them at Contact Us.
HOKUTO, under the leadership of President Dr. Sota Yamashita and Chairman Hokuto Igarashi, has been heavily focused on disseminating medical information, particularly in oncology, which arises from a growing demand for reliable and relevant information among its 100,000 physician members. Likewise, WJOG, led by Chairman Nobuyuki Yamamoto, has dedicated over 30 years to improving cancer treatment in Japan through collaborative clinical trials and physician-led research. They have also fostered an environment where young researchers can propose and conduct clinical studies independently, which is crucial for developing the next generation of professionals in the field amidst an aging organization.
Key Initiatives from the Partnership
The collaboration is set to roll out several major initiatives:
1. Dissemination of the latest research results and clinical trial information.
2. Publication of interviews with WJOG and associated medical institutions.
3. Production of content that elaborates on various aspects of oncology.
4. Promotion of upcoming seminars organized by WJOG.
Comments from WJOG Leadership
Nobuyuki Yamamoto expressed his excitement about the partnership, emphasizing the critical need for a reliable platform that ensures the swift and accurate transfer of accumulated knowledge from clinical trials directly to practitioners’ hands. He noted that HOKUTO's clinical support app, used by over 100,000 physicians nationwide, will serve as an excellent foundation for this information-sharing endeavor.
Mitsugu Miura, chair of WJOG’s Educational and Public Relations Committee, echoed this sentiment, highlighting the practical tools available through HOKUTO that enhance clinical practice. He anticipates that this partnership will significantly increase the dissemination of relevant information about clinical trials and seminars, ultimately contributing to the advancement of cancer care and increasing awareness of WJOG's activities among HOKUTO users.
About WJOG
Founded as a voluntary organization on lung cancer treatment over three decades ago, WJOG transitioned to a certified NPO in 2015 and now oversees collaborative clinical trials across 386 institutions with approximately 920 members. Their consistent focus on bridging clinical research and practice has led to the creation of specialized groups for young physicians in various fields.
HOKUTO's Role
The HOKUTO clinical support app offers a comprehensive service that assists physicians in accessing essential medical information both during and after working hours. The app is designed to reduce the burden of sifting through vast amounts of medical literature, enabling physicians to directly improve patient outcomes effectively.
Company Overview
HOKUTO, an innovative healthcare IT startup, strives to alleviate the work burden of medical professionals by providing necessary tools for medical and clinical support. Their product suite includes the HOKUTO clinical support app, alongside student residency assistance and marketing solutions for healthcare companies. The mission statement emphasizes their commitment to seeking better outcomes for healthcare professionals worldwide.
For more information on HOKUTO, please visit HOKUTO's corporate site. For inquiries, you can reach them at Contact Us.
Topics Health）
【About Using Articles】
You can freely use the title and article content by linking to the page where the article is posted.
※ Images cannot be used.
【About Links】
Links are free to use.